{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:03:59Z","timestamp":1793815439300,"version":"4.6.1"},"reference-count":60,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Transl. Med."],"published-print":{"date-parts":[[2009,11,4]]},"abstract":"<jats:p>\n                    Dysfunctional genotype combinations of polymorphic adenosine 5\u2032-triphosphate\u2013binding cassette transporter gene\n                    <jats:italic>ABCG2\/BCRP<\/jats:italic>\n                    , which encodes a high-capacity urate secretion transporter in human gut and kidney, are major causes of gout.\n                  <\/jats:p>","DOI":"10.1126\/scitranslmed.3000237","type":"journal-article","created":{"date-parts":[[2009,11,4]],"date-time":"2009-11-04T19:13:58Z","timestamp":1257362038000},"source":"Crossref","is-referenced-by-count":390,"title":["Common Defects of ABCG2, a High-Capacity Urate Exporter, Cause Gout: A Function-Based Genetic Analysis in a Japanese Population"],"prefix":"10.1126","volume":"1","author":[{"given":"Hirotaka","family":"Matsuo","sequence":"first","affiliation":[{"name":"Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tappei","family":"Takada","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The University of Tokyo Hospital, Faculty of Medicine, University of Tokyo, Tokyo 113-8655, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiyoshi","family":"Ichida","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan."},{"name":"Division of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo 105-8461, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Laboratory for Mathematics, Premedical Course, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan."},{"name":"Laboratory for Statistical Analysis, Center for Genomic Medicine, Institute of Physical and Chemical Research, Tokyo 108-8639, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan."},{"name":"Medical Platoon, 9th Aircraft Control and Warning Squadron, Japan Air Self-Defense Force, Satsuma-Sendai, Kagoshima 896-1411, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Ikebuchi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The University of Tokyo Hospital, Faculty of Medicine, University of Tokyo, Tokyo 113-8655, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousei","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The University of Tokyo Hospital, Faculty of Medicine, University of Tokyo, Tokyo 113-8655, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyoshi","family":"Kusanagi","sequence":"additional","affiliation":[{"name":"Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinori","family":"Chiba","sequence":"additional","affiliation":[{"name":"Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Tadokoro","sequence":"additional","affiliation":[{"name":"Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzo","family":"Takada","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Oikawa","sequence":"additional","affiliation":[{"name":"Department of Biology, Faculty of Science, Toho University, Funabashi, Chiba 274-8510, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Public Health, Fujita Health University, School of Health Sciences, Toyoake, Aichi 470-1192, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rieko","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine\/Biostatistics and Medical Decision Making, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichiro","family":"Nishiyama","sequence":"additional","affiliation":[{"name":"Japan Self-Defense Forces Hospital Yokosuka, Yokosuka, Kanagawa 237-0071, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideharu","family":"Domoto","sequence":"additional","affiliation":[{"name":"Medical Service Unit Kure, Japan Maritime Self-Defense Force, Kure, Hiroshima 737-8554, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Division of Environmental Medicine, National Defense Medical College Research Institute, Tokorozawa, Saitama 359-8513, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Fujita","sequence":"additional","affiliation":[{"name":"Division of Environmental Medicine, National Defense Medical College Research Institute, Tokorozawa, Saitama 359-8513, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Naito","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine\/Biostatistics and Medical Decision Making, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuko","family":"Nishio","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine\/Biostatistics and Medical Decision Making, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asahi","family":"Hishida","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine\/Biostatistics and Medical Decision Making, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Wakai","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine\/Biostatistics and Medical Decision Making, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yatami","family":"Asai","sequence":"additional","affiliation":[{"name":"Seirei Social Welfare Community, Hamamatsu, Shizuoka 430-0946, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Niwa","sequence":"additional","affiliation":[{"name":"Department of Biology, Faculty of Science, Toho University, Funabashi, Chiba 274-8510, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Kamakura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeaki","family":"Nonoyama","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Public Health, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Hosoya","sequence":"additional","affiliation":[{"name":"Division of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo 105-8461, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikatsu","family":"Kanai","sequence":"additional","affiliation":[{"name":"Division of Bio-system Pharmacology, Department of Pharmacology, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The University of Tokyo Hospital, Faculty of Medicine, University of Tokyo, Tokyo 113-8655, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Hamajima","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine\/Biostatistics and Medical Decision Making, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nariyoshi","family":"Shinomiya","sequence":"additional","affiliation":[{"name":"Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/ard.33.4.313","article-title":"Factors affecting urate solubility in vitro.","volume":"33","author":"Kippen I.","year":"1974","unstructured":"Kippen I., Klinenberg J. R., Weinberger A., Wilcox W. R., Factors affecting urate solubility in vitro. Ann. Rheum. Dis. 33, 313\u2013317 (1974).","journal-title":"Ann. Rheum. Dis."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk.","volume":"359","author":"Feig D. I.","year":"2008","unstructured":"Feig D. I., Kang D. H., Johnson R. J., Uric acid and cardiovascular risk. N. Engl. J. Med. 359, 1811\u20131821 (2008).","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.ackd.2006.01.008","article-title":"Genetic factors associated with gout and hyperuricemia.","volume":"13","author":"Bleyer A. J.","year":"2006","unstructured":"Bleyer A. J., Hart T. C., Genetic factors associated with gout and hyperuricemia. Adv. Chronic Kidney Dis. 13, 124\u2013130 (2006).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1056\/NEJMon060780","article-title":"The severe gout of Holy Roman Emperor Charles V.","volume":"355","author":"Ordi J.","year":"2006","unstructured":"Ordi J., Alonso P. L., de Zulueta J., Esteban J., Velasco M., Mas E., Campo E., Fern\u00e1ndez P. L., The severe gout of Holy Roman Emperor Charles V. N. Engl. J. Med. 355, 516\u2013520 (2006).","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1126\/science.313.5788.741b","article-title":"Ruler laid low by gout.","volume":"313","author":"Holden C.","year":"2006","unstructured":"Holden C., Ruler laid low by gout. Science 313, 741 (2006).","journal-title":"Science"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMp048015","article-title":"Uric acid and diet\u2014insights into the epidemic of cardiovascular disease.","volume":"350","author":"Johnson R. J.","year":"2004","unstructured":"Johnson R. J., Rideout B. A., Uric acid and diet\u2014insights into the epidemic of cardiovascular disease. N. Engl. J. Med. 350, 1071\u20131073 (2004).","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_8_2","first-page":"647","article-title":"Epidemiology of hyperuricemia and gout in Japan [in Japanese].","volume":"66","author":"Hakoda M.","year":"2008","unstructured":"Hakoda M., Epidemiology of hyperuricemia and gout in Japan [in Japanese]. Nippon Rinsho 66, 647\u2013652 (2008).","journal-title":"Nippon Rinsho"},{"key":"e_1_3_2_9_2","first-page":"1859","article-title":"Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China.","volume":"35","author":"Miao Z.","year":"2008","unstructured":"Miao Z., Li C., Chen Y., Zhao S., Wang Y., Wang Z., Chen X., Xu F., Wang F., Sun R., Hu J., Song W., Yan S., Wang C. Y., Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J. Rheumatol. 35, 1859\u20131864 (2008).","journal-title":"J. Rheumatol."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/ard.2004.024091","article-title":"Gout epidemiology: Results from the UK General Practice Research Database, 1990\u20131999.","volume":"64","author":"Mikuls T. R.","year":"2005","unstructured":"Mikuls T. R., Farrar J. T., Bilker W. B., Fernandes S., Schumacher H. R., Saag K. G., Gout epidemiology: Results from the UK General Practice Research Database, 1990\u20131999. Ann. Rheum. Dis. 64, 267\u2013272 (2005)","journal-title":"Ann. Rheum. Dis."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJM196609012750902","article-title":"Hyperuricemia in primary and renal hypertension.","volume":"275","author":"Cannon P. J.","year":"1966","unstructured":"Cannon P. J., Stason W. B., Demartini F. E., Sommers S. C., Laragh J. H., Hyperuricemia in primary and renal hypertension. N. Engl. J. Med. 275, 457\u2013464 (1966).","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/archinternmed.2008.521","article-title":"Uric acid and insulin sensitivity and risk of incident hypertension.","volume":"169","author":"Forman J. P.","year":"2009","unstructured":"Forman J. P., Choi H., Curhan G. C., Uric acid and insulin sensitivity and risk of incident hypertension. Arch. Intern. Med. 169, 155\u2013162 (2009).","journal-title":"Arch. Intern. Med."},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000235626","article-title":"Gouty arthritis in acute cerebrovascular disease.","volume":"28","author":"Lin Y. H.","year":"2009","unstructured":"Lin Y. H., Hsu H. L., Huang Y. C., Lee M., Huang W. Y., Huang Y. C., Lee T. H., Lee J. D., Gouty arthritis in acute cerebrovascular disease. Cerebrovasc. Dis. 28, 391\u2013396 (2009).","journal-title":"Cerebrovasc. Dis."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/art.24164","article-title":"Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: A Chinese cohort study.","volume":"61","author":"Chen J. H.","year":"2009","unstructured":"Chen J. H., Chuang S. Y., Chen H. J., Yeh W. T., Pan W. H., Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: A Chinese cohort study. Arthritis Rheum. 61, 225\u2013232 (2009).","journal-title":"Arthritis Rheum."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.ajkd.2005.10.006","article-title":"Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.","volume":"47","author":"Siu Y. P.","year":"2006","unstructured":"Siu Y. P., Leung K. T., Tong M. K., Kwan T. H., Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am. J. Kidney Dis. 47, 51\u201359 (2006).","journal-title":"Am. J. Kidney Dis."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1159\/000105142","article-title":"The effect of mild hyperuricemia on urinary transforming growth factor \u03b2 and the progression of chronic kidney disease.","volume":"27","author":"Talaat K. M.","year":"2007","unstructured":"Talaat K. M., el-Sheikh A. R., The effect of mild hyperuricemia on urinary transforming growth factor \u03b2 and the progression of chronic kidney disease. Am. J. Nephrol. 27, 435\u2013440 (2007).","journal-title":"Am. J. Nephrol."},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nature742","article-title":"Molecular identification of a renal urate anion exchanger that regulates blood urate levels.","volume":"417","author":"Enomoto A.","year":"2002","unstructured":"Enomoto A., Kimura H., Chairoungdua A., Shigeta Y., Jutabha P., Cha S. H., Hosoyamada M., Takeda M., Sekine T., Igarashi T., Matsuo H., Kikuchi Y., Oda T., Ichida K., Hosoya T., Shimokata K., Niwa T., Kanai Y., Endou H., Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 417, 447\u2013452 (2002).","journal-title":"Nature"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1371\/journal.pgen.0030194","article-title":"The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts.","volume":"3","author":"Li S.","year":"2007","unstructured":"Li S., Sanna S., Maschio A., Busonero F., Usala G., Mulas A., Lai S., Dei M., Orr\u00f9 M., Albai G., Bandinelli S., Schlessinger D., Lakatta E., Scuteri A., Najjar S. S., Guralnik J., Naitza S., Crisponi L., Cao A., Abecasis G., Ferrucci L., Uda M., Chen W. M., Nagaraja R., The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet. 3, e194 (2007).","journal-title":"PLoS Genet."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/ng.107","article-title":"SLC2A9 influences uric acid concentrations with pronounced sex-specific effects.","volume":"40","author":"D\u00f6ring A.","year":"2008","unstructured":"D\u00f6ring A., Gieger C., Mehta D., Gohlke H., Prokisch H., Coassin S., Fischer G., Henke K., Klopp N., Kronenberg F., Paulweber B., Pfeufer A., Rosskopf D., V\u00f6lzke H., Illig T., Meitinger T., Wichmann H. E., Meisinger C., SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat. Genet. 40, 430\u2013436 (2008).","journal-title":"Nat. Genet."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ng.106","article-title":"SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout.","volume":"40","author":"Vitart V.","year":"2008","unstructured":"Vitart V., Rudan I., Hayward C., Gray N. K., Floyd J., Palmer C. N., Knott S. A., Kolcic I., Polasek O., Graessler J., Wilson J. F., Marinaki A., Riches P. L., Shu X., Janicijevic B., Smolej-Narancic N., Gorgoni B., Morgan J., Campbell S., Biloglav Z., Barac-Lauc L., Pericic M., Klaric I. M., Zgaga L., Skaric-Juric T., Wild S. H., Richardson W. A., Hohenstein P., Kimber C. H., Tenesa A., Donnelly L. A., Fairbanks L. D., Aringer M., McKeigue P. M., Ralston S. H., Morris A. D., Rudan P., Hastie N. D., Campbell H., Wright A. F., SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat. Genet. 40, 437\u2013442 (2008).","journal-title":"Nat. Genet."},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ajhg.2008.11.001","article-title":"Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia.","volume":"83","author":"Matsuo H.","year":"2008","unstructured":"Matsuo H., Chiba T., Nagamori S., Nakayama A., Domoto H., Phetdee K., Wiriyasermkul P., Kikuchi Y., Oda T., Nishiyama J., Nakamura T., Morimoto Y., Kamakura K., Sakurai Y., Nonoyama S., Kanai Y., Shinomiya N., Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. Am. J. Hum. Genet. 83, 744\u2013751 (2008).","journal-title":"Am. J. Hum. Genet."},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1086\/423429","article-title":"Genomewide scan for gout in Taiwanese aborigines reveals linkage to chromosome 4q25.","volume":"75","author":"Cheng L. S.","year":"2004","unstructured":"Cheng L. S., Chiang S. L., Tu H. P., Chang S. J., Wang T. N., Ko A. M., Chakraborty R., Ko Y. C., Genomewide scan for gout in Taiwanese aborigines reveals linkage to chromosome 4q25. Am. J. Hum. Genet. 75, 498\u2013503 (2004).","journal-title":"Am. J. Hum. Genet."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(08)61343-4","article-title":"Association of three genetic loci with uric acid concentration and risk of gout: A genome-wide association study.","volume":"372","author":"Dehghan A.","year":"2008","unstructured":"Dehghan A., K\u00f6ttgen A., Yang Q., Hwang S. J., Kao W. L., Rivadeneira F., Boerwinkle E., Levy D., Hofman A., Astor B. C., Benjamin E. J., van Duijn C. M., Witteman J. C., Coresh J., Fox C. S., Association of three genetic loci with uric acid concentration and risk of gout: A genome-wide association study. Lancet 372, 1953\u20131961 (2008).","journal-title":"Lancet"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"e1000504","DOI":"10.1371\/journal.pgen.1000504","article-title":"Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations.","volume":"5","author":"Kolz M.","year":"2009","unstructured":"Kolz M., Johnson T., Sanna S., Teumer A., Vitart V., Perola M., Mangino M., Albrecht E., Wallace C., Farrall M., Johansson A., Nyholt D. R., Aulchenko Y., Beckmann J. S., Bergmann S., Bochud M., Brown M.H. Campbell; EUROSPAN Consortium, , Connell J., Dominiczak A., Homuth G., Lamina C.M. I. McCarthy; ENGAGE Consortium, , Meitinger T., Mooser V., Munroe P., Nauck M., Peden J., Prokisch H., Salo P., Salomaa V., Samani N. J., Schlessinger D., Uda M., V\u00f6lker U., Waeber G., Waterworth D., Wang-Sattler R., Wright A. F., Adamski J., Whitfield J. B., Gyllensten U., Wilson J. F., Rudan I., Pramstaller P.H. Watkins; PROCARDIS Consortium, , Doering A.H. E. Wichmann; KORA Study, , Spector T. D., Peltonen L., V\u00f6lzke H., Nagaraja R., Vollenweider P.M. Caulfield; WTCCC, , Illig T., Gieger C., Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet. 5, e1000504 (2009).","journal-title":"PLoS Genet."},{"key":"e_1_3_2_25_2","first-page":"3458","article-title":"Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.","volume":"61","author":"Maliepaard M.","year":"2001","unstructured":"Maliepaard M., Scheffer G. L., Faneyte I. F., van Gastelen M. A., Pijnenborg A. C., Schinkel A. H., van De Vijver M. J., Scheper R. J., Schellens J. H., Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res. 61, 3458\u20133464 (2001).","journal-title":"Cancer Res."},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/sj.ki.5002645","article-title":"The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane.","volume":"73","author":"Huls M.","year":"2008","unstructured":"Huls M., Brown C. D., Windass A. S., Sayer R., van den Heuvel J. J., Heemskerk S., Russel F. G., Masereeuw R., The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane. Kidney Int. 73, 220\u2013225 (2008).","journal-title":"Kidney Int."},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1124\/dmd.106.014274","article-title":"Abcg2\/Bcrp1 mediates the polarized transport of antiretroviral nucleosides abacavir and zidovudine.","volume":"35","author":"Pan G.","year":"2007","unstructured":"Pan G., Giri N., Elmquist W. F., Abcg2\/Bcrp1 mediates the polarized transport of antiretroviral nucleosides abacavir and zidovudine. Drug Metab. Dispos. 35, 1165\u20131173 (2007).","journal-title":"Drug Metab. Dispos."},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"6965","DOI":"10.1158\/0008-5472.CAN-06-4720","article-title":"Substrate overlap between Mrp4 and Abcg2\/Bcrp affects purine analogue drug cytotoxicity and tissue distribution.","volume":"67","author":"Takenaka K.","year":"2007","unstructured":"Takenaka K., Morgan J. A., Scheffer G. L., Adachi M., Stewart C. F., Sun D., Leggas M., Ejendal K. F., Hrycyna C. A., Schuetz J. D., Substrate overlap between Mrp4 and Abcg2\/Bcrp affects purine analogue drug cytotoxicity and tissue distribution. Cancer Res. 67, 6965\u20136972 (2007).","journal-title":"Cancer Res."},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1158\/1535-7163.MCT-08-0427","article-title":"Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides.","volume":"7","author":"de Wolf C.","year":"2008","unstructured":"de Wolf C., Jansen R., Yamaguchi H., de Haas M., van de Wetering K., Wijnholds J., Beijnen J., Borst P., Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides. Mol. Cancer Ther. 7, 3092\u20133102 (2008).","journal-title":"Mol. Cancer Ther."},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1023\/B:PHAM.0000045245.21637.d4","article-title":"Functional analysis of SNPs variants of BCRP\/ABCG2.","volume":"21","author":"Kondo C.","year":"2004","unstructured":"Kondo C., Suzuki H., Itoda M., Ozawa S., Sawada J., Kobayashi D., Ieiri I., Mine K., Ohtsubo K., Sugiyama Y., Functional analysis of SNPs variants of BCRP\/ABCG2. Pharm. Res. 21, 1895\u20131903 (2004).","journal-title":"Pharm. Res."},{"key":"e_1_3_2_31_2","unstructured":"D. A. Sica A. Schoolwerth Elements of normal renal structure and function: Renal handling of organic anions and cations in Brenner and Rector\u2019s The Kidney B. M. Brenner Ed. (Saunders Philadelphia ed. 7 2004) pp. 645\u2013649."},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/art.1780080429","article-title":"Role of the intestinal tract in the elimination of uric acid.","volume":"8","author":"Sorensen L. B.","year":"1965","unstructured":"Sorensen L. B., Role of the intestinal tract in the elimination of uric acid. Arthritis Rheum. 8, 694\u2013706 (1965).","journal-title":"Arthritis Rheum."},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"22644","DOI":"10.1074\/jbc.M212399200","article-title":"ABCG2 transports sulfated conjugates of steroids and xenobiotics.","volume":"278","author":"Suzuki M.","year":"2003","unstructured":"Suzuki M., Suzuki H., Sugimoto Y., Sugiyama Y., ABCG2 transports sulfated conjugates of steroids and xenobiotics. J. Biol. Chem. 278, 22644\u201322649 (2003).","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2133\/dmpk.21.109","article-title":"Genetic variation and haplotype structure of the ABC transporter gene ABCG2 in a Japanese population.","volume":"21","author":"Maekawa K.","year":"2006","unstructured":"Maekawa K., Itoda M., Sai K., Saito Y., Kaniwa N., Shirao K., Hamaguchi T., Kunitoh H., Yamamoto N., Tamura T., Minami H., Kubota K., Ohtsu A., Yoshida T., Saijo N., Kamatani N., Ozawa S., Sawada J., Genetic variation and haplotype structure of the ABC transporter gene ABCG2 in a Japanese population. Drug Metab. Pharmacokinet. 21, 109\u2013121 (2006).","journal-title":"Drug Metab. Pharmacokinet."},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"13778","DOI":"10.1021\/bi801644v","article-title":"Membrane topology of the human breast cancer resistance protein (BCRP\/ABCG2) determined by epitope insertion and immunofluorescence.","volume":"47","author":"Wang H.","year":"2008","unstructured":"Wang H., Lee E. W., Cai X., Ni Z., Zhou L., Mao Q., Membrane topology of the human breast cancer resistance protein (BCRP\/ABCG2) determined by epitope insertion and immunofluorescence. Biochemistry 47, 13778\u201313787 (2008).","journal-title":"Biochemistry"},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1126\/science.6137059","article-title":"Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines.","volume":"221","author":"Kartner N.","year":"1983","unstructured":"Kartner N., Riordan J. R., Ling V., Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 221, 1285\u20131288 (1983).","journal-title":"Science"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1168750"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1360704"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5252.1126"},{"key":"e_1_3_2_41_2","first-page":"3537","article-title":"Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.","volume":"57","author":"Kool M.","year":"1997","unstructured":"Kool M., de Haas M., Scheffer G. L., Scheper R. J., van Eijk M. J., Juijn J. A., Baas F., Borst P., Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 57, 3537\u20133547 (1997).","journal-title":"Cancer Res."},{"key":"e_1_3_2_42_2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1349-7006.2006.00371.x","article-title":"Re-evaluation and functional classification of non-synonymous single nucleotide polymorphisms of the human ATP-binding cassette transporter ABCG2.","volume":"98","author":"Tamura A.","year":"2007","unstructured":"Tamura A., Wakabayashi K., Onishi Y., Takeda M., Ikegami Y., Sawada S., Tsuji M., Matsuda Y., Ishikawa T., Re-evaluation and functional classification of non-synonymous single nucleotide polymorphisms of the human ATP-binding cassette transporter ABCG2. Cancer Sci. 98, 231\u2013239 (2007).","journal-title":"Cancer Sci."},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cca.2006.05.010","article-title":"Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males.","volume":"373","author":"Zhang W.","year":"2006","unstructured":"Zhang W., Yu B. N., He Y. J., Fan L., Li Q., Liu Z. Q., Wang A., Liu Y. L., Tan Z. R., Fen-Jiang , Huang Y. F., Zhou H. H., Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males. Clin. Chim. Acta 373, 99\u2013103 (2006).","journal-title":"Clin. Chim. Acta"},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/jnci\/djj469","article-title":"Pharmacogenetics of ABCG2 and adverse reactions to gefitinib.","volume":"98","author":"Cusatis G.","year":"2006","unstructured":"Cusatis G., Gregorc V., Li J., Spreafico A., Ingersoll R. G., Verweij J., Ludovini V., Villa E., Hidalgo M., Sparreboom A., Baker S. D., Pharmacogenetics of ABCG2 and adverse reactions to gefitinib. J. Natl. Cancer Inst. 98, 1739\u20131742 (2006).","journal-title":"J. Natl. Cancer Inst."},{"key":"e_1_3_2_45_2","first-page":"6447","article-title":"The breast cancer resistance protein (Bcrp1\/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.","volume":"63","author":"van Herwaarden A. E.","year":"2003","unstructured":"van Herwaarden A. E., Jonker J. W., Wagenaar E., Brinkhuis R. F., Schellens J. H., Beijnen J. H., Schinkel A. H., The breast cancer resistance protein (Bcrp1\/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Res. 63, 6447\u20136452 (2003).","journal-title":"Cancer Res."},{"key":"e_1_3_2_46_2","doi-asserted-by":"crossref","first-page":"15649","DOI":"10.1073\/pnas.202607599","article-title":"The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria.","volume":"99","author":"Jonker J. W.","year":"2002","unstructured":"Jonker J. W., Buitelaar M., Wagenaar E., Van Der Valk M. A., Scheffer G. L., Scheper R. J., Plosch T., Kuipers F., Elferink R. P., Rosing H., Beijnen J. H., Schinkel A. H., The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc. Natl. Acad. Sci. U.S.A. 99, 15649\u201315654 (2002).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"e_1_3_2_47_2","doi-asserted-by":"crossref","first-page":"9412","DOI":"10.1073\/pnas.86.23.9412","article-title":"Urate oxidase: Primary structure and evolutionary implications.","volume":"86","author":"Wu X. W.","year":"1989","unstructured":"Wu X. W., Lee C. C., Muzny D. M., Caskey C. T., Urate oxidase: Primary structure and evolutionary implications. Proc. Natl. Acad. Sci. U.S.A. 86, 9412\u20139416 (1989).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1126\/science.3344434","article-title":"Generation of cDNA probes directed by amino acid sequence: Cloning of urate oxidase.","volume":"239","author":"Lee C. C.","year":"1988","unstructured":"Lee C. C., Wu X. W., Gibbs R. A., Cook R. G., Muzny D. M., Caskey C. T., Generation of cDNA probes directed by amino acid sequence: Cloning of urate oxidase. Science 239, 1288\u20131291 (1988).","journal-title":"Science"},{"key":"e_1_3_2_49_2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0167-4943(84)90033-5","article-title":"Urate and ascorbate: Their possible roles as antioxidants in determining longevity of mammalian species.","volume":"3","author":"Cutler R. G.","year":"1984","unstructured":"Cutler R. G., Urate and ascorbate: Their possible roles as antioxidants in determining longevity of mammalian species. Arch. Gerontol. Geriatr. 3, 321\u2013348 (1984).","journal-title":"Arch. Gerontol. Geriatr."},{"key":"e_1_3_2_50_2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1750-1172-2-48","article-title":"Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome.","volume":"2","author":"Torres R. J.","year":"2007","unstructured":"Torres R. J., Puig J. G., Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome. Orphanet. J. Rare Dis. 2, 48 (2007).","journal-title":"Orphanet. J. Rare Dis."},{"key":"e_1_3_2_51_2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0925-4439(99)00103-9","article-title":"Kelley-Seegmiller syndrome due to a unique variant of hypoxanthine-guanine phosphoribosyltransferase: Reduced affinity for 5-phosphoribosyl-1-pyrophosphate manifested only at low, physiological substrate concentrations.","volume":"1500","author":"Zoref-Shani E.","year":"2000","unstructured":"Zoref-Shani E., Feinstein S., Frishberg Y., Bromberg Y., Sperling O., Kelley-Seegmiller syndrome due to a unique variant of hypoxanthine-guanine phosphoribosyltransferase: Reduced affinity for 5-phosphoribosyl-1-pyrophosphate manifested only at low, physiological substrate concentrations. Biochim. Biophys. Acta 1500, 197\u2013203 (2000).","journal-title":"Biochim. Biophys. Acta"},{"key":"e_1_3_2_52_2","doi-asserted-by":"crossref","first-page":"26476","DOI":"10.1016\/S0021-9258(19)74339-7","article-title":"Human X-linked phosphoribosylpyrophosphate synthetase superactivity is associated with distinct point mutations in the PRPS1 gene.","volume":"268","author":"Roessler B. J.","year":"1993","unstructured":"Roessler B. J., Nosal J. M., Smith P. R., Heidler S. A., Palella T. D., Switzer R. L., Becker M. A., Human X-linked phosphoribosylpyrophosphate synthetase superactivity is associated with distinct point mutations in the PRPS1 gene. J. Biol. Chem. 268, 26476\u201326481 (1993).","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.179.4078.1123"},{"key":"e_1_3_2_54_2","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/1529-0131(200004)43:4<925::AID-ANR26>3.0.CO;2-B","article-title":"Localization of a gene for familial juvenile hyperuricemic nephropathy causing underexcretion-type gout to 16p12 by genome-wide linkage analysis of a large family.","volume":"43","author":"Kamatani N.","year":"2000","unstructured":"Kamatani N., Moritani M., Yamanaka H., Takeuchi F., Hosoya T., Itakura M., Localization of a gene for familial juvenile hyperuricemic nephropathy causing underexcretion-type gout to 16p12 by genome-wide linkage analysis of a large family. Arthritis Rheum. 43, 925\u2013929 (2000).","journal-title":"Arthritis Rheum."},{"key":"e_1_3_2_55_2","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/jmg.39.12.882","article-title":"Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy.","volume":"39","author":"Hart T. C.","year":"2002","unstructured":"Hart T. C., Gorry M. C., Hart P. S., Woodard A. S., Shihabi Z., Sandhu J., Shirts B., Xu L., Zhu H., Barmada M. M., Bleyer A. J., Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J. Med. Genet. 39, 882\u2013892 (2002).","journal-title":"J. Med. Genet."},{"key":"e_1_3_2_56_2","doi-asserted-by":"crossref","first-page":"10338","DOI":"10.1073\/pnas.0901249106","article-title":"Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout.","volume":"106","author":"Woodward O. M.","year":"2009","unstructured":"Woodward O. M., K\u00f6ttgen A., Coresh J., Boerwinkle E., Guggino W. B., K\u00f6ttgen M., Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc. Natl. Acad. Sci. U.S.A. 106, 10338\u201310342 (2009).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1167728"},{"key":"e_1_3_2_58_2","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/archneur.56.6.721","article-title":"Familial paroxysmal dystonic choreoathetosis: Clinical findings in a large Japanese family and genetic linkage to 2q.","volume":"56","author":"Matsuo H.","year":"1999","unstructured":"Matsuo H., Kamakura K., Saito M., Okano M., Nagase T., Tadano Y., Kaida K., Hirata A., Miyamoto N., Masaki T., Nakamura R., Motoyoshi K., Tanaka H., Tsuji S., Familial paroxysmal dystonic choreoathetosis: Clinical findings in a large Japanese family and genetic linkage to 2q. Arch. Neurol. 56, 721\u2013726 (1999).","journal-title":"Arch. Neurol."},{"key":"e_1_3_2_59_2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/(SICI)1096-8628(19991215)88:6<733::AID-AJMG27>3.0.CO;2-3","article-title":"Mutational analysis of the anion exchanger 3 gene in familial paroxysmal dystonic choreoathetosis linked to chromosome 2q.","volume":"88","author":"Matsuo H.","year":"1999","unstructured":"Matsuo H., Kamakura K., Matsushita S., Ohmori T., Okano M., Tadano Y., Tsuji S., Higuchi S., Mutational analysis of the anion exchanger 3 gene in familial paroxysmal dystonic choreoathetosis linked to chromosome 2q. Am. J. Med. Genet. 88, 733\u2013737 (1999).","journal-title":"Am. J. Med. Genet."},{"key":"e_1_3_2_60_2","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1124\/dmd.104.000497","article-title":"Hepatic transport of PKI166, an epidermal growth factor receptor kinase inhibitor of the pyrrolo-pyrimidine class, and its main metabolite, ACU154","volume":"32","author":"Takada T.","year":"2004","unstructured":"Takada T., Weiss H. M., Kretz O., Gross G., Sugiyama Y., Hepatic transport of PKI166, an epidermal growth factor receptor kinase inhibitor of the pyrrolo-pyrimidine class, and its main metabolite, ACU154, Drug Metab. Dispos. 32, 1272\u20131278 (2004).","journal-title":"Drug Metab. Dispos."},{"key":"e_1_3_2_61_2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1124\/mol.107.043034","article-title":"Niemann-Pick C1-like 1 mediates \u03b1-tocopherol transport.","volume":"74","author":"Narushima K.","year":"2008","unstructured":"Narushima K., Takada T., Yamanashi Y., Suzuki H., Niemann-Pick C1-like 1 mediates \u03b1-tocopherol transport. Mol. Pharmacol. 74, 42\u201349 (2008).","journal-title":"Mol. Pharmacol."},{"key":"e_1_3_2_62_2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1469-1809.2002.00112.x","article-title":"Determination of probability distribution of diplotype configuration (diplotype distribution) for each subject from genotypic data using the EM algorithm.","volume":"66","author":"Kitamura Y.","year":"2002","unstructured":"Kitamura Y., Moriguchi M., Kaneko H., Morisaki H., Morisaki T., Toyama K., Kamatani N., Determination of probability distribution of diplotype configuration (diplotype distribution) for each subject from genotypic data using the EM algorithm. Ann. Hum. Genet. 66, 183\u2013193 (2002).","journal-title":"Ann. Hum. Genet."}],"container-title":["Science Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/scitranslmed.3000237","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T12:37:17Z","timestamp":1705408637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.3000237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,4]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,11,4]]}},"alternative-id":["10.1126\/scitranslmed.3000237"],"URL":"https:\/\/doi.org\/10.1126\/scitranslmed.3000237","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13353973.14725071","asserted-by":"object"}]},"ISSN":["1946-6234","1946-6242"],"issn-type":[{"value":"1946-6234","type":"print"},{"value":"1946-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,4]]}}}